These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 8776731
1. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens. Galien R, Evans HF, Garcia T. Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731 [Abstract] [Full Text] [Related]
2. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity. Merola M, Blanchard B, Tovey MG. J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763 [Abstract] [Full Text] [Related]
3. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Galien R, Garcia T. Nucleic Acids Res; 1997 Jun 15; 25(12):2424-9. PubMed ID: 9171095 [Abstract] [Full Text] [Related]
4. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. Kurebayashi S, Miyashita Y, Hirose T, Kasayama S, Akira S, Kishimoto T. J Steroid Biochem Mol Biol; 1997 Jan 15; 60(1-2):11-7. PubMed ID: 9182853 [Abstract] [Full Text] [Related]
5. [Synergism between transcription factors NF-IL6 and NF-kappa B in IL-6 gene regulation]. Fujikawa K. Hokkaido Igaku Zasshi; 1992 Jul 15; 67(4):563-74. PubMed ID: 1427600 [Abstract] [Full Text] [Related]
6. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Stein B, Yang MX. Mol Cell Biol; 1995 Sep 15; 15(9):4971-9. PubMed ID: 7651415 [Abstract] [Full Text] [Related]
7. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta. Quaedackers ME, Van Den Brink CE, Wissink S, Schreurs RH, Gustafsson JA, Van Der Saag PT, Van Der Burg BB. Endocrinology; 2001 Mar 15; 142(3):1156-66. PubMed ID: 11181531 [Abstract] [Full Text] [Related]
8. Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line. Faggioli L, Costanzo C, Merola M, Bianchini E, Furia A, Carsana A, Palmieri M. Eur J Biochem; 1996 Aug 01; 239(3):624-31. PubMed ID: 8774705 [Abstract] [Full Text] [Related]
9. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells. Mondal D, Alam J, Prakash O. J Mol Neurosci; 1996 Aug 01; 5(4):241-58. PubMed ID: 7577367 [Abstract] [Full Text] [Related]
10. Lipopolysaccharide-mediated induction of the bovine interleukin-6 gene in monocytes requires both NF-kappa B and C/EBP binding sites. Ray A, Ray BK. DNA Cell Biol; 1995 Sep 01; 14(9):795-802. PubMed ID: 7669256 [Abstract] [Full Text] [Related]
11. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Stein B, Baldwin AS. Mol Cell Biol; 1993 Nov 01; 13(11):7191-8. PubMed ID: 8413306 [Abstract] [Full Text] [Related]
12. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, Stern D. J Biol Chem; 1995 May 12; 270(19):11463-71. PubMed ID: 7744784 [Abstract] [Full Text] [Related]
13. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. Ray P, Ghosh SK, Zhang DH, Ray A. FEBS Lett; 1997 Jun 02; 409(1):79-85. PubMed ID: 9199508 [Abstract] [Full Text] [Related]
14. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. Kunsch C, Lang RK, Rosen CA, Shannon MF. J Immunol; 1994 Jul 01; 153(1):153-64. PubMed ID: 8207232 [Abstract] [Full Text] [Related]
15. Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells. Li X, Liao WS. Nucleic Acids Res; 1992 Sep 25; 20(18):4765-72. PubMed ID: 1408789 [Abstract] [Full Text] [Related]
16. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulation. Dokter WH, Koopmans SB, Vellenga E. Leukemia; 1996 Aug 25; 10(8):1308-16. PubMed ID: 8709636 [Abstract] [Full Text] [Related]
17. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts. Bodine PV, Harris HA, Komm BS. Endocrinology; 1999 Jun 25; 140(6):2439-51. PubMed ID: 10342828 [Abstract] [Full Text] [Related]
18. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene. Huo B, Dossing DA, Dimuzio MT. J Bone Miner Res; 1995 May 25; 10(5):769-81. PubMed ID: 7639112 [Abstract] [Full Text] [Related]
19. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NF kappa B-like transcription factors. Li XX, Liao WS. J Biol Chem; 1991 Aug 15; 266(23):15192-201. PubMed ID: 1869549 [Abstract] [Full Text] [Related]
20. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Wang W, Dong L, Saville B, Safe S. Mol Endocrinol; 1999 Aug 15; 13(8):1373-87. PubMed ID: 10446910 [Abstract] [Full Text] [Related] Page: [Next] [New Search]